Moreover, there is evidence that the VAPB-PTPIP51 interaction is also disrupted in Alzheimer’s disease and Parkinson’s disease; notably TDP43 pathology is a feature of both these diseases [28, 40, 45]. Here, RMDN3 is linked to Alzheimer disease.